Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors

Sandeepraj Pusalkar, Swapan K. Chowdhury|Drug Metabolism and Disposition|2020

Cited by 16